Epigallocatechin-3-gallate (EGCG)-stabilized selenium nanoparticles coated with Tet-1 peptide to reduce amyloid-β aggregation and cytotoxicity

ACS Applied Materials and Interfaces

Volumn 6, Issue 11, 2014, Pages 8475-8487

  Zhang, Jingnan ^a   Zhou, Xianbo ^a   Yu, Qianqian ^a   Yang, Licong ^a   Sun, Dongdong ^a   Zhou, Yanhui ^a   Liu, Jie ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

amyloid; epigallocatechin 3 gallate; fibril; oligomer; selenium nanoparticles

Indexed keywords

CELLS; CYTOLOGY; GLYCOPROTEINS; NANOPARTICLES; NEURODEGENERATIVE DISEASES; OLIGOMERS; PEPTIDES; SELENIUM;

ALZHEIMER'S DISEASE; AMYLOID; ANTI-OXIDATION; CELLULAR UPTAKE; EPIGALLOCATECHIN-3-GALLATE; FIBRIL; NEUROPROTECTION; SELENIUM NANOPARTICLES;

SYNTHESIS (CHEMICAL);

AMYLOID BETA PROTEIN; CATECHIN; EPIGALLOCATECHIN GALLATE; METAL NANOPARTICLE; SELENIUM;

ANALOGS AND DERIVATIVES; ANIMAL; CELL SURVIVAL; CHEMISTRY; PC12 CELL LINE; RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; CATECHIN; CELL SURVIVAL; METAL NANOPARTICLES; PC12 CELLS; RATS; SELENIUM;

EID: 84902438468     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/am501341u     Document Type: Article

References (49)

1. Kosik, K. S. Alzheimer's Disease: a Cell Biological Perspective Science 1992, 256, 780-783
2. Yamin, G.; Ono, K.; Inayathullah, M.; Teplow, D. B. Amyloid-Protein Assembly as a Therapeutic Target of Alzheimers Disease Curr. Pharm. Des. 2008, 14, 3231-3246
3. Rafii, M. S.; Aisen, P. S. Recent Developments in Alzheimer's DiseaseTherapeutics BMC Med. 2009, 7, 7
4. Abbott, A. Dementia: a Problem for Our Age Nature 2011, 475, S2-S4
5. Iqbal, K.; Grundke-Iqbal, I. Developing Pharmacological Therapies for Alzheimer Disease Cell. Mol. Life Sci. 2007, 64, 2234-2244
6. Youdim, M. B.; Buccafusco, J. J. Multi-functional Drugs for Various CNS Targets in the Treatment of Neurodegenerative Disorders Trends Pharmacol. Sci. 2005, 26, 27-35
7. Park, S.-Y.; Kim, H.-S.; Cho, E.-K.; Kwon, B.-Y.; Phark, S.; Hwang, K.-W.; Sul, D. Curcumin Protected PC12 Cells Against Beta-Amyloid-induced Toxicity Through the Inhibition of Oxidative Damage and Tau Hyperphosphorylation Food Chem. Toxicol. 2008, 46, 2881-2887
8. Lim, G. P.; Chu, T.; Yang, F.; Beech, W.; Frautschy, S. A.; Cole, G. M. The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse J. Neurosci. 2001, 21, 8370-8377
9. Chen, T.; Wang, X.; He, Y.; Zhang, C.; Wu, Z.; Liao, K.; Wang, J.; Guo, Z. Effects of Cyclen and Cyclam on Zinc (II)-and Copper (II)-induced Amyloid β-peptide Aggregation and Neurotoxicity Inorg. Chem. 2009, 48, 5801-5809
10. Wang, X.; Wang, X.; Zhang, C.; Jiao, Y.; Guo, Z. Inhibitory Action of Macrocyclic Platiniferous Chelators on Metal-induced Aβ Aggregation Chem. Sci. 2012, 3, 1304-1312
11. Geng, J.; Li, M.; Ren, J.; Wang, E.; Qu, X. Polyoxometalates as Inhibitors of the Aggregation of Amyloid β Peptides Associated with Alzheimer's Disease Angew. Chem. 2011, 123, 4270-4274
12. Doss, M. X.; Potta, S. P.; Hescheler, J.; Sachinidis, A. Trapping of Growth Gactors by Catechins: a Possible Therapeutical Target for Prevention of Proliferative Diseases J. Nutr. Biochem. 2005, 16, 259-266
13. Weinreb, O.; Amit, T.; Mandel, S.; Youdim, M. B. Neuroprotective Molecular Mechanisms of (-)-Epigallocatechin-3-gallate: a Reflective Outcome of its Antioxidant, Iron Chelating and Neuritogenic Properties Genes Nutr. 2009, 4, 283-296
14. Biasibetti, R.; Tramontina, A. C.; Costa, A. P.; Dutra, M. F.; Quincozes-Santos, A.; Nardin, P.; Bernardi, C. L.; Wartchow, K. M.; Lunardi, P. S.; Gonçalves, C.-A. Green Tea (-)-Epigallocatechin-3-gallate Reverses Oxidative Stress and Reduces Acetylcholinesterase Activity in a Streptozotocin-induced Model of Dementia Behav. Brain Res. 2013, 236, 186-193
15. Rezai-Zadeh, K.; Arendash, G. W.; Hou, H.; Fernandez, F.; Jensen, M.; Runfeldt, M.; Shytle, R. D.; Tan, J. Green Tea Epigallocatechin-3-gallate (EGCG) Reduces β-Amyloid Mediated Cognitive Impairment and Modulates Tau Pathology in Alzheimer Transgenic Mice Brain Res. 2008, 1214, 177-187
16. Bieschke, J.; Russ, J.; Friedrich, R. P.; Ehrnhoefer, D. E.; Wobst, H.; Neugebauer, K.; Wanker, E. E. EGCG Remodels Mature α-Synuclein and Amyloid-β Fibrils and Reduces Cellular Toxicity Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 7710-7715
17. Ferreira, N.; Cardoso, I.; Domingues, M. R.; Vitorino, R.; Bastos, M.; Bai, G.; Saraiva, M. J.; Almeida, M. R. Binding of Epigallocatechin-3-gallate to Transthyretin Modulates its Amyloidogenicity FEBS Lett. 2009, 583, 3569-3576
18. Ehrnhoefer, D. E.; Duennwald, M.; Markovic, P.; Wacker, J. L.; Engemann, S.; Roark, M.; Legleiter, J.; Marsh, J. L.; Thompson, L. M.; Lindquist, S. Green Tea (-)-Epigallocatechin-gallate Modulates Early Events in Huntingtin Misfolding and Reduces Toxicity in Huntington's Disease Models Hum. Mol. Genet. 2006, 15, 2743-2751
19. Ehrnhoefer, D. E.; Bieschke, J.; Boeddrich, A.; Herbst, M.; Masino, L.; Lurz, R.; Engemann, S.; Pastore, A.; Wanker, E. E. EGCG Redirects Amyloidogenic Polypeptides into Unstructured, Off-pathway Oligomers Nat. Struct. Mol. Biol. 2008, 15, 558-566
20. Engel, M. F.; VandenAkker, C. C.; Schleeger, M.; Velikov, K. P.; Koenderink, G. H.; Bonn, M. The Polyphenol EGCG Inhibits Amyloid Formation Less Efficiently at Phospholipid Interfaces Than in Bulk Solution J. Am. Chem. Soc. 2012, 134, 14781-14788
21. Hudson, S. A.; Ecroyd, H.; Dehle, F. C.; Musgrave, I. F.; Carver, J. A. (-)-Epigallocatechin-3-gallate (EGCG) Maintains κ-casein in its Pre-fibrillar State Without Redirecting its Aggregation Pathway J. Mol. Biol. 2009, 392, 689-700
22. Palhano, F. L.; Lee, J.; Grimster, N. P.; Kelly, J. W. Toward the Molecular Mechanism(s) by Which EGCG Treatment Remodels Mature Amyloid Fibrils J. Am. Chem. Soc. 2013, 135, 7503-7510
23. Siddiqui, I. A.; Mukhtar, H. Nanochemoprevention by Bioactive Food Components: a Perspective Pharm. Res. 2010, 27, 1054-1060
24. Smith, A.; Giunta, B.; Bickford, P. C.; Fountain, M.; Tan, J.; Shytle, R. D. Nanolipidic Particles Improve the Bioavailability and α-secretase Inducing Ability of Epigallocatechin-3-gallate (EGCG) for the Treatment of Alzheimer's Disease Int. J. Pharm. 2010, 389, 207-212
25. Dube, A.; Nicolazzo, J. A.; Larson, I. Chitosan Nanoparticles Enhance the Plasma Exposure of (-)-Epigallocatechin Gallate in Mice Through an Enhancement in Intestinal Stability Eur. J. Pharm. Sci. 2011, 44, 422-426
26. Siddiqui, I. A.; Adhami, V. M.; Bharali, D. J.; Hafeez, B. B.; Asim, M.; Khwaja, S. I.; Ahmad, N.; Cui, H.; Mousa, S. A.; Mukhtar, H. Introducing Nanochemoprevention as a Novel Approach for Cancer Control: Proof of Principle with Green Tea Polyphenol Epigallocatechin-3-gallate Cancer Res. 2009, 69, 1712-1716
27. Godoi, G. L.; de Oliveira Porciúncula, L.; Schulz, J. F.; Kaufmann, F. N.; da Rocha, J. B.; de Souza, D. O. G.; Ghisleni, G.; de Almeida, H. L., Jr. Selenium Compounds Prevent Amyloid β-Peptide Neurotoxicity in Rat Primary Hippocampal Neurons Neurochem. Res. 2013, 38, 2359-2363
28. Kryukov, G. V.; Castellano, S.; Novoselov, S. V.; Lobanov, A. V.; Zehtab, O.; Guigó, R.; Gladyshev, V. N. Characterization of Mammalian Selenoproteomes Science 2003, 300, 1439-1443
29. Bellinger, F.; Raman, A.; Reeves, M.; Berry, M. Regulation and Function of Selenoproteins in Human Disease Biochem. J. 2009, 422, 11-22
30. Loef, M.; Schrauzer, G. N.; Walach, H. Selenium and Alzheimer's Disease: a Systematic Review J. Alzheimer's Dis. 2011, 26, 81-104
31. Park, I. K.; Lasiene, J.; Chou, S. H.; Horner, P. J.; Pun, S. H. Neuron-Specific Delivery of Nucleic Acids Mediated by Tet1-modified Poly(Ethylenimine) J. Gen. Intern. Med. 2007, 9, 691-702
32. Liu, J. K.; Teng, Q.; Garrity-Moses, M.; Federici, T.; Tanase, D.; Imperiale, M. J.; Boulis, N. M. A novel Peptide Defined Through Phage Display for Therapeutic Protein and Vector Neuronal Targeting Neurobiol. Dis. 2005, 19, 407-418
33. Mathew, A.; Fukuda, T.; Nagaoka, Y.; Hasumura, T.; Morimoto, H.; Yoshida, Y.; Maekawa, T.; Venugopal, K.; Kumar, D. S. Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer's Disease PloS One 2012, 7, e32616
34. Yu, H.; Ren, J.; Qu, X. Different Hydration Changes Accompanying Copper and Zinc Binding to Amyloid β-Peptide: Water Contribution to Metal Binding ChemBioChem 2008, 9, 879-882
35. Song, Y.; Qu, K.; Xu, C.; Ren, J.; Qu, X. Visual and Quantitative Detection of Copper Ions Using Magnetic Silica Nanoparticles Clicked on Multiwalled Carbon Nanotubes Chem. Commun. 2010, 46, 6572-6574
36. Geng, J.; Qu, K.; Ren, J.; Qu, X. Rapid and Efficient Screening of Alzheimer's Disease β-Amyloid Inhibitors Using Label-Free Gold Nanoparticles Mol. Biosyst. 2010, 6, 2389-2391
37. 2 J. Biol. Chem. 2002, 277, 40302-40308
38. Cimini, A.; D'Angelo, B.; Das, S.; Gentile, R.; Benedetti, E.; Singh, V.; Monaco, A. M.; Santucci, S.; Seal, S. Antibody-Conjugated PEGylated Cerium Oxide Nanoparticles for Specific Targeting of Aβ Aggregates Modulate Neuronal Survival Pathways Acta Biomater. 2012, 8, 2056-2067
39. Liao, R.; Tang, Z.; Lei, Y.; Guo, B. Polyphenol-Reduced Graphene Oxide: Mechanism and Derivatization J. Phys. Chem. C 2011, 115, 20740-20746
40. Soto, C. Protein Misfolding and Disease; Protein Refolding andTherapy FEBS Lett. 2001, 498, 204-207
41. Biancalana, M.; Koide, S. Molecular Mechanism of Thioflavin-T Binding to Amyloid Fibrils Biochim. Biophys. Acta, Proteins Proteomics 2010, 1804, 1405-1412
42. Jiang, T.; Zhi, X.-L.; Zhang, Y.-H.; Pan, L.-F.; Zhou, P. Inhibitory Effect of Curcumin on the Al (III)-induced Aβ< > 42<> Aggregation and Neurotoxicity in Vitro Biochim. Biophys. Acta, Mol. Basis Dis. 2012, 1822, 1207-1215
43. Levine, H.; Thioflavine, T. Interaction with Synthetic Alzheimer's Disease β-Amyloid Peptides: Detection of Amyloid Aggregation in Solution Protein Sci. 1993, 2, 404-410
44. Lopez del Amo, J. M.; Fink, U.; Dasari, M.; Grelle, G.; Wanker, E. E.; Bieschke, J.; Reif, B. Structural Properties of EGCG-induced, Nontoxic Alzheimer's Disease Aβ Oligomers J. Mol. Biol. 2012, 421, 517-524
45. Gupta, S.; Babu, P.; Surolia, A. Biphenyl Ethers Conjugated CdSe/ZnS Core/Shell Quantum Dots and Interpretation of the Mechanism of Amyloid Fibril Disruption Biomaterials 2010, 31, 6809-6822
46. Saraiva, A. M.; Cardoso, I.; Saraiva, M. J.; Tauer, K.; Pereira, M. C.; Coelho, M. A.; Möhwald, H.; Brezesinski, G. Randomization of Amyloid-β-Peptide (1-42) Conformation by Sulfonated and Sulfated Nanoparticles Reduces Aggregation and Cytotoxicity Macromol. Biosci. 2010, 10, 1152-1163
47. Pi, R.; Mao, X.; Chao, X.; Cheng, Z.; Liu, M.; Duan, X.; Ye, M.; Chen, X.; Mei, Z.; Liu, P. Tacrine-6-Ferulic Acid, a Novel Multifunctional Dimer, Inhibits Amyloid-β-Mediated Alzheimer's Disease-Associated Pathogenesis In Vitro and In Vivo PloS One 2012, 7, e31921
48. Chonpathompikunlert, P.; Yoshitomi, T.; Han, J.; Isoda, H.; Nagasaki, Y. The Use of Nitroxide Radical-containing Nanoparticles Coupled with Piperine to Protect Neuroblastoma SH-SY5Y Cells from Aβ-induced Oxidative Stress Biomaterials 2011, 32, 8605-8612
49. Omtri, R. S.; Davidson, M. W.; Arumugam, B.; Poduslo, J. F.; Kandimalla, K. K. Differences in the Cellular Uptake and Intracellular Itineraries of Amyloid Beta Proteins 40 and 42: Ramifications for the Alzheimer's Drug Discovery Mol. Pharm. 2012, 9, 1887-1897